+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergy Treatment Market 2025-2029

  • PDF Icon

    Report

  • 205 Pages
  • December 2024
  • Region: Global
  • TechNavio
  • ID: 6037143
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The allergy treatment market is forecasted to grow by USD 9.93 billion during 2024-2029, accelerating at a CAGR of 6.8% during the forecast period. The report on the allergy treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing focus on food based allergy treatment, programs for allergy treatments, and new product launches.

The allergy treatment market is segmented as below:

By Therapeutic Area

  • Pharmacological
  • Non-pharmacological

By Type

  • Rhinitis
  • Asthma
  • Skin allergy
  • Eye
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the strong pipeline as one of the prime reasons driving the allergy treatment market growth during the next few years. Also, focus on clinical trials and approval of novel therapies will lead to sizable demand in the market.

The report on the allergy treatment market covers the following areas:

  • Allergy Treatment Market sizing
  • Allergy Treatment Market forecast
  • Allergy Treatment Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy treatment market vendors that include AbbVie Inc., ALK Abello AS, ALLERGOPHARMA GmbH and Co. KG, Allergy Therapeutics PLCA, Almirall SA, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Danaher Corp., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, HAL Allergy BV, LETI Pharma SLU, Merck and Co. Inc., Nicox S.A., Novartis AG, Pfizer Inc., and Sanofi SA. Also, the allergy treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Allergy Treatment Market 2019 - 2023
Historic Market Size - Data Table on Global Allergy Treatment Market 2019 - 2023 ($ million)
5.2 Therapeutic Area segment analysis 2019 - 2023
Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
5.3 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact of Artificial Intelligence (AI) in Global Allergy Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Therapeutic Area
8.1 Market segments
Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)
8.2 Comparison by Therapeutic Area
Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area
8.3 Pharmacological - Market size and forecast 2024-2029
Chart on Pharmacological - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmacological - Market size and forecast 2024-2029 ($ million)
Chart on Pharmacological - Year-over-year growth 2024-2029 (%)
Data Table on Pharmacological - Year-over-year growth 2024-2029 (%)
8.4 Non-pharmacological - Market size and forecast 2024-2029
Chart on Non-pharmacological - Market size and forecast 2024-2029 ($ million)
Data Table on Non-pharmacological - Market size and forecast 2024-2029 ($ million)
Chart on Non-pharmacological - Year-over-year growth 2024-2029 (%)
Data Table on Non-pharmacological - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Therapeutic Area
Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)
9 Market Segmentation by Type
9.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
9.3 Rhinitis - Market size and forecast 2024-2029
Chart on Rhinitis - Market size and forecast 2024-2029 ($ million)
Data Table on Rhinitis - Market size and forecast 2024-2029 ($ million)
Chart on Rhinitis - Year-over-year growth 2024-2029 (%)
Data Table on Rhinitis - Year-over-year growth 2024-2029 (%)
9.4 Asthma - Market size and forecast 2024-2029
Chart on Asthma - Market size and forecast 2024-2029 ($ million)
Data Table on Asthma - Market size and forecast 2024-2029 ($ million)
Chart on Asthma - Year-over-year growth 2024-2029 (%)
Data Table on Asthma - Year-over-year growth 2024-2029 (%)
9.5 Skin allergy - Market size and forecast 2024-2029
Chart on Skin allergy - Market size and forecast 2024-2029 ($ million)
Data Table on Skin allergy - Market size and forecast 2024-2029 ($ million)
Chart on Skin allergy - Year-over-year growth 2024-2029 (%)
Data Table on Skin allergy - Year-over-year growth 2024-2029 (%)
9.6 Eye - Market size and forecast 2024-2029
Chart on Eye - Market size and forecast 2024-2029 ($ million)
Data Table on Eye - Market size and forecast 2024-2029 ($ million)
Chart on Eye - Year-over-year growth 2024-2029 (%)
Data Table on Eye - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
11.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.10 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
11.11 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
11.12 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.13 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.14 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
11.15 Australia - Market size and forecast 2024-2029
Chart on Australia - Market size and forecast 2024-2029 ($ million)
Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Chart on Australia - Year-over-year growth 2024-2029 (%)
Data Table on Australia - Year-over-year growth 2024-2029 (%)
11.16 Italy - Market size and forecast 2024-2029
Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
14.5 ALK Abello AS
ALK Abello AS - Overview
ALK Abello AS - Product / Service
ALK Abello AS - Key offerings
SWOT
14.6 ALLERGOPHARMA GmbH and Co. KG
ALLERGOPHARMA GmbH and Co. KG - Overview
ALLERGOPHARMA GmbH and Co. KG - Product / Service
ALLERGOPHARMA GmbH and Co. KG - Key offerings
SWOT
14.7 Allergy Therapeutics PLCA
Allergy Therapeutics PLCA - Overview
Allergy Therapeutics PLCA - Product / Service
Allergy Therapeutics PLCA - Key offerings
SWOT
14.8 Almirall SA
Almirall SA - Overview
Almirall SA - Product / Service
Almirall SA - Key news
Almirall SA - Key offerings
SWOT
14.9 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
SWOT
14.10 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
SWOT
14.11 Danaher Corp.
Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
SWOT
14.12 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
14.13 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
SWOT
14.14 LETI Pharma SLU
LETI Pharma SLU - Overview
LETI Pharma SLU - Product / Service
LETI Pharma SLU - Key offerings
SWOT
14.15 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
14.16 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
14.17 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
14.18 Sanofi SA
Sanofi SA - Overview
Sanofi SA - Business segments
Sanofi SA - Key news
Sanofi SA - Key offerings
Sanofi SA - Segment focus
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 11: Overview on criticality of inputs and factors of differentiation
Exhibits 12: Overview on factors of disruption
Exhibits 13: Impact of drivers and challenges in 2024 and 2029
Exhibits 14: Parent Market
Exhibits 15: Data Table on - Parent Market
Exhibits 16: Market characteristics analysis
Exhibits 17: Value chain analysis
Exhibits 18: Offerings of companies included in the market definition
Exhibits 19: Market segments
Exhibits 20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Historic Market Size - Data Table on Global Allergy Treatment Market 2019 - 2023 ($ million)
Exhibits 25: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 29: Five forces analysis - Comparison between 2024 and 2029
Exhibits 30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 35: Chart on Market condition - Five forces 2024 and 2029
Exhibits 36: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 37: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 38: Chart on Comparison by Therapeutic Area
Exhibits 39: Data Table on Comparison by Therapeutic Area
Exhibits 40: Chart on Pharmacological - Market size and forecast 2024-2029 ($ million)
Exhibits 41: Data Table on Pharmacological - Market size and forecast 2024-2029 ($ million)
Exhibits 42: Chart on Pharmacological - Year-over-year growth 2024-2029 (%)
Exhibits 43: Data Table on Pharmacological - Year-over-year growth 2024-2029 (%)
Exhibits 44: Chart on Non-pharmacological - Market size and forecast 2024-2029 ($ million)
Exhibits 45: Data Table on Non-pharmacological - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Chart on Non-pharmacological - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Non-pharmacological - Year-over-year growth 2024-2029 (%)
Exhibits 48: Market opportunity by Therapeutic Area ($ million)
Exhibits 49: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits 50: Chart on Type - Market share 2024-2029 (%)
Exhibits 51: Data Table on Type - Market share 2024-2029 (%)
Exhibits 52: Chart on Comparison by Type
Exhibits 53: Data Table on Comparison by Type
Exhibits 54: Chart on Rhinitis - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Rhinitis - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Rhinitis - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Rhinitis - Year-over-year growth 2024-2029 (%)
Exhibits 58: Chart on Asthma - Market size and forecast 2024-2029 ($ million)
Exhibits 59: Data Table on Asthma - Market size and forecast 2024-2029 ($ million)
Exhibits 60: Chart on Asthma - Year-over-year growth 2024-2029 (%)
Exhibits 61: Data Table on Asthma - Year-over-year growth 2024-2029 (%)
Exhibits 62: Chart on Skin allergy - Market size and forecast 2024-2029 ($ million)
Exhibits 63: Data Table on Skin allergy - Market size and forecast 2024-2029 ($ million)
Exhibits 64: Chart on Skin allergy - Year-over-year growth 2024-2029 (%)
Exhibits 65: Data Table on Skin allergy - Year-over-year growth 2024-2029 (%)
Exhibits 66: Chart on Eye - Market size and forecast 2024-2029 ($ million)
Exhibits 67: Data Table on Eye - Market size and forecast 2024-2029 ($ million)
Exhibits 68: Chart on Eye - Year-over-year growth 2024-2029 (%)
Exhibits 69: Data Table on Eye - Year-over-year growth 2024-2029 (%)
Exhibits 70: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 71: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 72: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 74: Market opportunity by Type ($ million)
Exhibits 75: Data Table on Market opportunity by Type ($ million)
Exhibits 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 77: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 78: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 79: Chart on Geographic comparison
Exhibits 80: Data Table on Geographic comparison
Exhibits 81: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 82: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 84: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 85: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 86: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 88: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 89: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 90: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 92: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 93: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 137: Market opportunity By Geographical Landscape ($ million)
Exhibits 138: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 139: Impact of drivers and challenges in 2024 and 2029
Exhibits 140: Overview on criticality of inputs and factors of differentiation
Exhibits 141: Overview on factors of disruption
Exhibits 142: Impact of key risks on business
Exhibits 143: Companies covered
Exhibits 144: Company ranking index
Exhibits 145: Matrix on companies position and classification
Exhibits 146: AbbVie Inc. - Overview
Exhibits 147: AbbVie Inc. - Product / Service
Exhibits 148: AbbVie Inc. - Key news
Exhibits 149: AbbVie Inc. - Key offerings
Exhibits 150: SWOT
Exhibits 151: ALK Abello AS - Overview
Exhibits 152: ALK Abello AS - Product / Service
Exhibits 153: ALK Abello AS - Key offerings
Exhibits 154: SWOT
Exhibits 155: ALLERGOPHARMA GmbH and Co. KG - Overview
Exhibits 156: ALLERGOPHARMA GmbH and Co. KG - Product / Service
Exhibits 157: ALLERGOPHARMA GmbH and Co. KG - Key offerings
Exhibits 158: SWOT
Exhibits 159: Allergy Therapeutics PLCA - Overview
Exhibits 160: Allergy Therapeutics PLCA - Product / Service
Exhibits 161: Allergy Therapeutics PLCA - Key offerings
Exhibits 162: SWOT
Exhibits 163: Almirall SA - Overview
Exhibits 164: Almirall SA - Product / Service
Exhibits 165: Almirall SA - Key news
Exhibits 166: Almirall SA - Key offerings
Exhibits 167: SWOT
Exhibits 168: Bayer AG - Overview
Exhibits 169: Bayer AG - Business segments
Exhibits 170: Bayer AG - Key news
Exhibits 171: Bayer AG - Key offerings
Exhibits 172: Bayer AG - Segment focus
Exhibits 173: SWOT
Exhibits 174: Boehringer Ingelheim International GmbH - Overview
Exhibits 175: Boehringer Ingelheim International GmbH - Product / Service
Exhibits 176: Boehringer Ingelheim International GmbH - Key news
Exhibits 177: Boehringer Ingelheim International GmbH - Key offerings
Exhibits 178: SWOT
Exhibits 179: Danaher Corp. - Overview
Exhibits 180: Danaher Corp. - Business segments
Exhibits 181: Danaher Corp. - Key news
Exhibits 182: Danaher Corp. - Key offerings
Exhibits 183: Danaher Corp. - Segment focus
Exhibits 184: SWOT
Exhibits 185: F. Hoffmann La Roche Ltd. - Overview
Exhibits 186: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 187: F. Hoffmann La Roche Ltd. - Key news
Exhibits 188: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 189: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 190: SWOT
Exhibits 191: GlaxoSmithKline Plc - Overview
Exhibits 192: GlaxoSmithKline Plc - Business segments
Exhibits 193: GlaxoSmithKline Plc - Key news
Exhibits 194: GlaxoSmithKline Plc - Key offerings
Exhibits 195: GlaxoSmithKline Plc - Segment focus
Exhibits 196: SWOT
Exhibits 197: LETI Pharma SLU - Overview
Exhibits 198: LETI Pharma SLU - Product / Service
Exhibits 199: LETI Pharma SLU - Key offerings
Exhibits 200: SWOT
Exhibits 201: Merck and Co. Inc. - Overview
Exhibits 202: Merck and Co. Inc. - Business segments
Exhibits 203: Merck and Co. Inc. - Key news
Exhibits 204: Merck and Co. Inc. - Key offerings
Exhibits 205: Merck and Co. Inc. - Segment focus
Exhibits 206: SWOT
Exhibits 207: Novartis AG - Overview
Exhibits 208: Novartis AG - Business segments
Exhibits 209: Novartis AG - Key news
Exhibits 210: Novartis AG - Key offerings
Exhibits 211: Novartis AG - Segment focus
Exhibits 212: SWOT
Exhibits 213: Pfizer Inc. - Overview
Exhibits 214: Pfizer Inc. - Product / Service
Exhibits 215: Pfizer Inc. - Key news
Exhibits 216: Pfizer Inc. - Key offerings
Exhibits 217: SWOT
Exhibits 218: Sanofi SA - Overview
Exhibits 219: Sanofi SA - Business segments
Exhibits 220: Sanofi SA - Key news
Exhibits 221: Sanofi SA - Key offerings
Exhibits 222: Sanofi SA - Segment focus
Exhibits 223: SWOT
Exhibits 224: Inclusions checklist
Exhibits 225: Exclusions checklist
Exhibits 226: Currency conversion rates for US$
Exhibits 227: Research methodology
Exhibits 228: Information sources
Exhibits 229: Data validation
Exhibits 230: Validation techniques employed for market sizing
Exhibits 231: Data synthesis
Exhibits 232: 360 degree market analysis
Exhibits 233: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global allergy treatment market: AbbVie Inc., ALK Abello AS, ALLERGOPHARMA GmbH and Co. KG, Allergy Therapeutics PLCA, Almirall SA, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Danaher Corp., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, HAL Allergy BV, LETI Pharma SLU, Merck and Co. Inc., Nicox S.A., Novartis AG, Pfizer Inc., and Sanofi SA.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strong pipeline."

According to the report, one of the major drivers for this market is the increasing focus on food based allergy treatment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • ALK Abello AS
  • ALLERGOPHARMA GmbH and Co. KG
  • Allergy Therapeutics PLCA
  • Almirall SA
  • AstraZeneca Plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • HAL Allergy BV
  • LETI Pharma SLU
  • Merck and Co. Inc.
  • Nicox S.A.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA